YOU ARE HERE:
Side-effects news
page  of 19
 
Headline
Date
  Low bone mineral density common in HIV-positive men
19.11.09
  Pregnancy, not nevirapine cause of liver toxicities in HIV-positive women
18.11.09
  Small case series looks at etravirine during pregnancy
16.11.09
  Warning issued about rare etravirine allergic reactions
21.10.09
  Discovery of enzyme structure points way to creating less toxic anti-HIV drugs
16.10.09
  Stopping efavirenz due to CNS side-effects not associated with blood levels of the drug
14.10.09
  Abacavir impairs endothelial function, possibly explaining increased heart attack risk
30.09.09
  Inflammation signals heart disease risk in people with HIV
23.09.09
  Tobacco, marijuana and alcohol may lower levels of some anti-HIV drugs
21.09.09
  Risk of kidney problems similar for tenofovir and alternative drugs
25.08.09
  IRIS responsible for low number of deaths in patients starting HIV treatment in Uganda
18.08.09
  More evidence of bone loss with HIV therapy, more confusion over the role of specific drugs
13.08.09
  ddI treatment sole risk factor for noncirrhotic portal hypertension
29.07.09
  Low bone mineral density in Botswana PrEP trial participants raises concerns
24.07.09
  Two new analyses add to abacavir cardiovascular risk debate
21.07.09
  Stepped doses reduce incidence and severity of efavirenz-related side-effects
08.07.09
  HIV treatment and traditional risk factors causing hardening of the arteries
06.07.09
  HIV infection alone does not increase risk of diabetes
19.06.09
  d4T toxicity risk seven-fold higher when started with TB treatment
18.06.09
  Viral load associated with kidney function in patients with HIV
27.05.09

page  of 19